Patient Registries and Rare Diseases
Researchers are turning to patient registries to fill rare-disease knowledge gaps.
Clinical Trials vs Registries
Similarities exist, but successful design requires that CROs understand the differences.
Keeping Approvals on Track
Registries could strengthen the postapproval safety net-critical in the current cautious environment.
Rescuing Drugs Through Personalized Medicine
A new paradigm that could transform a drug failure into a drug success would narrow the target population to those patients most likely to benefit from such treatment.